Total Payments
$1,659
2024 Payments
$21.49
Companies
8
Transactions
11
Medicare Patients
2,087
Medicare Billing
$248,167
Payment Breakdown by Category
Consulting$1,000 (60.3%)
Food & Beverage$658.73 (39.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,000 | 1 | 60.3% |
| Food and Beverage | $658.73 | 10 | 39.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sebela Pharmaceuticals Inc. | $1,000 | 1 | $0 (2017) |
| Aries Pharmaceuticals, Inc. | $244.88 | 2 | $0 (2017) |
| AbbVie, Inc. | $124.98 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $102.73 | 1 | $0 (2017) |
| PFIZER INC. | $102.61 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $38.63 | 2 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $23.41 | 1 | $0 (2018) |
| Cook Medical LLC | $21.49 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.49 | 2 | Cook Medical LLC ($21.49) |
| 2019 | $102.61 | 1 | PFIZER INC. ($102.61) |
| 2018 | $187.02 | 4 | AbbVie, Inc. ($124.98) |
| 2017 | $1,348 | 4 | Sebela Pharmaceuticals Inc. ($1,000) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $12.66 | General |
| Category: Endoscopy | ||||||
| 03/21/2024 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $8.83 | General |
| Category: Endoscopy | ||||||
| 05/29/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $102.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/22/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2018 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Endocrinology | ||||||
| 12/07/2017 | Aries Pharmaceuticals, Inc. | ELEVIEW (Device) | Food and Beverage | Cash or cash equivalent | $125.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2017 | Aries Pharmaceuticals, Inc. | ELEVIEW (Device) | Food and Beverage | Cash or cash equivalent | $119.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/05/2017 | Sebela Pharmaceuticals Inc. | MOTOFEN (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 05/03/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $102.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 634 | 1,975 | $995,861 | $85,530 |
| 2022 | 12 | 555 | 626 | $772,276 | $58,019 |
| 2021 | 10 | 462 | 470 | $673,258 | $54,769 |
| 2020 | 10 | 436 | 448 | $648,701 | $49,848 |
Total Patients
2,087
Total Services
3,519
Medicare Billing
$248,167
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 167 | 168 | $364,500 | $33,268 | 9.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,260 | $95,760 | $23,085 | 24.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 131 | 132 | $227,735 | $6,765 | 3.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 89 | 91 | $136,500 | $6,054 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 43 | $13,330 | $3,917 | 29.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 29 | 31 | $6,820 | $1,861 | 27.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $19,260 | $1,855 | 9.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $20,865 | $1,795 | 8.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 26 | 36 | $8,100 | $1,644 | 20.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $23,500 | $1,471 | 6.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 21 | $4,620 | $1,323 | 28.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 13 | $56,706 | $1,180 | 2.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 60 | $4,500 | $619.73 | 13.8% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 15 | 15 | $2,835 | $347.69 | 12.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 12 | 60 | $10,830 | $344.14 | 3.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 144 | 144 | $306,436 | $28,398 | 9.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 126 | 126 | $213,110 | $7,238 | 3.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 86 | 89 | $130,830 | $6,105 | 4.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 53 | $16,059 | $4,175 | 26.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 18 | 18 | $28,314 | $2,933 | 10.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $27,624 | $1,973 | 7.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 31 | 37 | $8,140 | $1,566 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 23 | $4,945 | $1,469 | 29.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $18,876 | $1,412 | 7.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 19 | $4,071 | $1,227 | 30.1% |
About Dr. David Olson, MD
Dr. David Olson, MD is a Internal Medicine healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1407144744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Olson, MD has received a total of $1,659 in payments from pharmaceutical and medical device companies, with $21.49 received in 2024. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($1,000).
As a Medicare-enrolled provider, Olson has provided services to 2,087 Medicare beneficiaries, totaling 3,519 services with total Medicare billing of $248,167. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Charlotte, NC
- Active Since 07/20/2011
- Last Updated 07/15/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407144744
Products in Payments
- MOTOFEN (Drug) $1,000
- ELEVIEW (Device) $244.88
- Creon (Drug) $124.98
- INVOKANA (Drug) $102.73
- XELJANZ (Drug) $102.61
- XIFAXAN (Drug) $38.63
- CLENPIQ (Drug) $23.41
- HEMOSPRAY (Device) $21.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charlotte
Ryan Jacobs, Md, MD
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Saad Usmani, Md, MD
Internal Medicine — Payments: $747,509
Internal Medicine $747,509
Michael Rinaldi, Md, MD
Internal Medicine — Payments: $646,787
Internal Medicine $646,787
Dr. Richard Browne, M.d, M.D
Internal Medicine — Payments: $638,169
Internal Medicine $638,169
Sanjeev Gulati, Md, MD
Internal Medicine — Payments: $598,822
Internal Medicine $598,822
Dr. Raymond Thertulien, M.d, M.D
Internal Medicine — Payments: $584,601
Internal Medicine $584,601